Tilman B Drueke
Drüeke, Tilman B.
Drüeke, Tilman
VIAF ID: 70648607 (Personal)
Permalink: http://viaf.org/viaf/70648607
Preferred Forms
-
- 100 1 _ ‡a Drüeke, Tilman B.
- 100 1 0 ‡a Drüeke, Tilman B.
-
- 100 1 _ ‡a Drüeke, Tilman
- 100 1 _ ‡a Drüeke, Tilman B
-
-
- 100 0 _ ‡a Tilman B Drueke
4xx's: Alternate Name Forms (3)
Works
Title | Sources |
---|---|
[(99m)Tc]-sestamibi parathyroid scintigraphy in chronic haemodialysis patients: static and dynamic explorations | |
Athérosclérose accélérée et calcifications vasculaire : apport des modèles expérimentaux d'insuffisance rénale chronique. | |
Cellules parathyroïdiennes humaines pathologiques en culture : rôle du calcium, du calcitriol, du phosphate et d'un agoniste partiel du récepteur du calcium (NPS R-467) sur la sécrétion d'hormone parathyroïdienne et la prolifération cellulaire | |
Cinétique intradialytique de la ß2M plasmatique en fonction de la membrane d'hémodialyse utilisée | |
La dialyse intestinale chez le porc : étude de modificateurs de la perméabilité jejunale en vue d'une application à l'homme | |
Dialysis amyloid | |
EFFET DU 22-OXA-CALCITRIOL, ANALOGUE DE LA VITAMINE D, SUR LE TRANSPORT INTESTINAL DU CALCIUM ET LE METABOLISME PHOSPHOCALCIQUE CHEZ LE RAT UREMIQUE AYANT UNE HYPERPARATHYROIDIE SECONDAIRE MAJEURE | |
An Epidemiological Study of Hemodialysis Patients Based on the European Fresenius Medical Care Hemodialysis Network: Results of the ARO Study | |
Erythropoietin increases blood pressure in normotensive and hypertensive rats | |
ETUDES IN VITRO ET IN VIVO SUR LA REGULATION DU RECEPTEUR DE L'HORMONE PARATHYROIDIENNE (PTH) ET DU PEPTIDE APPARENTE A LA PTH (PTHRP) | |
Evaluation of bone remodeling in hemodialysis patients: serum biochemistry, circulating cytokines and bone histomorphometry | |
Evaluation of plasma neurotoxin concentration in uraemic polyneuropathic patients | |
[Factors determining the choice of a modality of treatment by dialysis: a study of nine dialysis centers] | |
Factors of increase in serum triglyceride-rich lipoproteins in uremic rats. | |
Fetuin-A protects against atherosclerotic calcification in CKD. | |
FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages. | |
[French-Brazilian school of nephrology] | |
Gastrointestinal absorption of aluminum in rats using 26Al and accelerator mass spectrometry | |
[Gram-negative vascular puncture infections in patients with hemodialysis] | |
[Hematologic disorders observed in patients following renal transplantation] | |
Hemodiafiltration Versus Hemodialysis and Survival in Patients With ESRD: The French Renal Epidemiology and Information Network (REIN) Registry | |
[Hemoglobin target for chronic kidney disease patients?] | |
Homocyst(e)ine, oxidative stress, and endothelium function in uremic patients. | |
Hypercalciuria during experimental vitamin K deficiency in the rat. | |
Hyperhomocysteinaemia: a significant risk factor for cardiovascular disease in renal transplant recipients | |
[Hyperparathyroidism and anemia: experimental study in the rat (author's transl)] | |
Hypertension Control, Apparent Treatment Resistance, and Outcomes in the Elderly Population With Chronic Kidney Disease. | |
Hypocalcaemic effect of WR-2721, S-2 (3-aminopropylamino) ethyl-phosphorothioic acid in an anuric haemodialysis patient | |
Hyporesponsiveness to recombinant human erythropoietin | |
Impact of disturbances of calcium and phosphate metabolism on vascular calcification and clinical outcomes in patients with chronic kidney disease. | |
Impossibility to study crystalluria directly with Coulter Counter | |
Improved phosphorus binder for hyperphosphataemia prevention in patients on dialysis | |
Improvement of post-heparin lipolytic activity (PHLA) after haemofiltration, in uraemic patients | |
Improving global outcomes in mineral and bone disorders | |
[In vitro effect of citrate and phosphates on calcium transport in the rat ileum] | |
In vitro studies of endotoxin transfer across cellulosic and noncellulosic dialysis membranes. II. Interleukin-1 production | |
[Inclan's tumoral calcinosis or Teutschlaender's lipocalcinogranulomatosis: possible pathogenic role of vitamin K] | |
Increased nitrogen removal from the intestinal tract of uraemic patients. | |
Increased potassium permeability in erythrocytes from patients with hyperparathyroidism | |
Inflammation Modifies the Paradoxical Association between Body Mass Index and Mortality in Hemodialysis Patients. | |
Influence of end-stage renal failure on concentrations of free apolipoprotein A-1 in serum | |
Influence of haemodialysis membranes on beta 2-microglobulin kinetics: in vivo and in vitro studies | |
[Influence of microinflammation and oxidative stress on atherosclerosis progression and calcifications in cardiovascular system of hemodialyzed patients during two years follow-up] | |
Influence of various calcium intakes on calcium-oxalate crystalluria in rats on sodium-oxalate diet | |
Inhibition of nitric oxide synthesis attenuates insulin-mediated sympathetic activation in rats | |
Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers | |
Insuffisance rénale, dialyse et transplantation dans les maladies rénales héréditaires | |
Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients? | |
Interleukin-2 production and targeting in hemodialyzed patients | |
Intestinal absorption of calcium from yogurt in lactase-deficient subjects | |
Intestinal calcium transport in the spontaneously hypertensive rat. | |
Intestinal elimination of uremic metabolites by the adsorbents | |
Investigations on clinico-chemical correlations in uraemic polyneuritis | |
Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. | |
[Is aluminum poisoning unavoidable in the uremic patient?] | |
Is parathyroid hormone measurement useful for the diagnosis of renal bone disease? | |
Isolement, purification et caractérisation d'une glycoprotéine urinaire inhibant la cristallisation de l'oxalate de calcium in vitro | |
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). | |
Kinetics of erythropoiesis in dialysis patients receiving recombinant erythropoietin treatment | |
Klotho, FGF23, and FGF receptors in chronic kidney disease: a yin-yang situation? | |
Klotho spins the thread of life--what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)? | |
Lanthanum carbonate, body lanthanum accumulation and potential liver toxicity | |
Lanthanum carbonate, like sevelamer-HCl, retards the progression of vascular calcification and atherosclerosis in uremic apolipoprotein E-deficient mice. | |
Left ventricular function in hemodialyzed patients with cardiomegaly | |
Left ventricular geometry predicts cardiovascular outcomes associated with anemia correction in CKD. | |
Letter: Chenodeoxycholic acid: possible intestinal injury | |
Letter: Dialysis for renal failure in patient with sickle-cell disease | |
[Lipid metabolism disorders in chronic kidney failure] | |
[Lipids, monocytes and progression of renal insufficiency] | |
Localization of ectopic parathyroid tissue: usefulness of 99mTc sestamibi scanning in a dialysis patient with severe secondary hyperparathyroidism | |
Localization of parathyroid tumors by ultrasonography | |
A new era in the treatment of calcium oxalate stones? | |
New insights into atherosclerosis and vascular calcification in an experimental mouse model of chronic renal failure | |
ROLE DES ANOMALIES DES LIPOPROTEINES DANS LA PROGRESSION DES LESIONS RENALES EXPERIMENTALES : INFLUENCE DES INHIBITEURS DE L'HYDROXY-METHYL-GLUTARYL COENZYME A | |
Le sel dans tous ses etats : vrai/faux sur un aliment trop critique |